Navigation Links
VersaPulse 80/100 Watt

ProductsVersaPulse 80/100 Watt
Company Lumenis, Inc.
Item VersaPulse 80/100 Watt
Features 
  • Highest power holmium laserup to 100 watts with 2 joules at 50 hertzprovides the smoothest cutting, faster, more efficient tissue effect, and reduced OR time
  • Upgrade capability for current and future applications
  • The only combination holmium/Nd:YAG laser system that provides multiple tissue effects through one delivery device
  • Compact size simplifies transportation and set-up
  • Solid state design with thirty-second warm-up for immediate use and problem-free maintenance
  • Over twenty fiber delivery systems compatible with multiple endoscopes
  • Description The VersaPulse PowerSuite holmium laser combines excellent cutting, ablation and coagulation properties for precise, virtually bloodless procedures. It is also extremely effective in fragmenting urinary and gall bladder stones of all compositions, making it an ideal multipurpose surgical tool. Because its laser light is transmitted through flexible fibers, it is especially suited for minimally invasive endoscopic and laparoscopic procedures. The VersaPulse PowerSuite system comes in a variety of low- to high-power holmium models plus a combination holmium and neodymium:YAG (Nd:YAG) configuration.

    Lumenis is the pioneer in laser and light-based technology. Since introducing the first medical laser in 1970, over 60,000 systems have been used by nearly every medical specialty. Since introducing the first holmium laser in 1991, Lumenis has helped to expand the medical applications of this relatively new multipurpose laser. Today, holmium technology has been proven in thousands of procedures, securing the holmium laser its place as a well-respected minimally invasive treatment modality and the VersaPulse PowerSuite as the system of choice.

    VersaPulse PowerSuite lasers are used for ablation, excision, incision, vaporization and immediate hemostasis of soft tissues through endoscopic, laparoscopic and open access for a wide variety of surgical applications and procedures.

    Info Lumenis, Inc.
    Customer Service: 877-lumenis
    Web site: http://www.lumenis.com

    Related medicine products :

    1. VersaPulse® 20 Watt
    2. VersaPulse® 60 Watt
    3. VersaPulse® 100 Watt
    4. VersaPulse® 80/100 Watt
    5. VersaPulse 60 Watt
    6. VersaPulse 20 Watt
    7. VersaPulse 100 Watt
    8. Lumenis VersaPulse PowerSuite
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products:
    (Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
    (Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
    (Date:1/22/2015)... released a new blog post presenting the basic features of ... an accidental death and dismemberment rider for a car insurance ... benefits if the insured dies in an accident. Accidental death ... insurance. , AD&D is not expensive and can be ...
    (Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
    (Date:1/22/2015)... years since the release of their debut recording Love is King, ... & Matthew Love – the duo are pleased to announce their ... Swan Records on February 24, 2015. , THE ROAD offers the ... all of us to walk out of the mire of our ...
    Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
    ... VIEW, Calif., March 4 Based on ... biotechnology market, Frost & Sullivan presents OVATION ... Frost & Sullivan Award for Entrepreneurial Company ... company,s success in achieving its growth objectives ...
    ... 4 Cardiogenesis Corporation (Pink Sheets: CGCP), announced that ... and full year ended December 31, 2008 prior to ... company also said that President Richard P. Lanigan and ... Abbott will host an investor conference call that day ...
    ... NVC-422 Demonstrates Ability to Treat Subcutaneous InfectionsEMERYVILLE, Calif., ... NBY), a clinical stage biopharmaceutical company, today announced ... lead molecule in NovaBay,s, proprietary Aganocide(R) class of ... of Dermatology (AAD) 67th Annual Meeting in San ...
    ... ,Smart, house for people with dementia are just ... on 4th March, organised by the Engineering and ... is a free event aiming to bring together, ... business people. The event includes a dynamic, interactive ...
    ... Long Looked For Ways To Whiten Teeth In The Comfort Of Their Own ... As In The Dentist Office. A New Teeth Whitening Product, Hollywood Sexy Smile, ... Same Results Without The Costs and Hassles Of Going To The Dentist Office. ... ...
    ... drugs and endocrine-disrupting compounds found in our public drinking water are ... report by the Water Research Foundation, the nation,s leading drinking water ... ... 2009 -- The concentrations of pharmaceutical drugs and endocrine-disrupting compounds found ...
    Cached Medicine News:Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 2Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 3Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 4Health News:Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st 2Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 2Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 3Health News:Daisyphone, virtual cocoon and smart house at London science conference 2Health News:Teeth Whitening Ranks Most Desired Cosmetic Procedure For Women. Hollywood Sexy Smile Whitens Teeth At Home 8 Shades Without The Dentist. 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 3Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 4
    (Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
    (Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
    (Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
    Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11